Latest / Wise & Well Presented by Community Memorial Healthcare / Pulse Field Ablation and the Future of AFib Treatment
Transcript
- 0:04Scott Webb (Host): Welcome to Wise and Well, presented by
- 0:06Community Memorial Healthcare.
- 0:08I'm Scott Webb.
- 0:09There are a few forms of ablation that are used for heart rhythm disorders
- 0:13like AFib, but pulsed field ablation is fast becoming the gold standard.
- 0:17And my guest today, electrophysiologist, Dr.
- 0:19Jonathan Dukes, is here to tell us how it works and how patients are benefiting
- 0:23from this revolutionary technology.
- 0:25Doctor, it's nice to have you back on the podcast.
- 0:26Today, we're going to talk more electrophysiology, of course.
- 0:29And let's just do that.
- 0:30Like, what exactly is that when I say electrophysiology?
- 0:34And why is it so crucial for addressing heart rhythm disorders?
- 0:38Dr. Jonathan Dukes:
- 0:38Electrophysiology is, at least for me, a very interesting specialty.
- 0:41It's a subspecialty of cardiology, meaning that it's a subset of cardiac
- 0:46care within the cardiology field.
- 0:48And what we do is we deal just with heart rhythms: too fast,
- 0:52too slow, regular, irregular.
- 0:54We're the ones that are trying to make your heart beat more
- 0:56regularly at a normal rate.
- 0:59So, patients are sent to us that have heart rates that are going
- 1:01too fast, patients that are feeling palpitations, feeling lightheaded
- 1:04and dizziness, passing out.
- 1:06These are all symptoms that would prompt a visit to an electrophysiologist.
- 1:10We also can deal with devices such as pacemakers and defibrillators.
- 1:13These are devices that are designed to help the heart not go so slow, or in
- 1:18cases of patients that have heart failure.
- 1:19These devices can both lengthen your life, prevent sudden cardiac death,
- 1:26and patients that pass out because of very fast heart rhythms, it can reset
- 1:30your heart to bring you back alive
- 1:33Host: Yeah.
- 1:33And I've had other heart experts on, heart doctors on, and they've simplified
- 1:36it for people like me and listeners that, you know, some heart docs are
- 1:41plumbers, some are electricians, and you're more the electrician type.
- 1:45And I want to have you give listeners just a sense anyway of the
- 1:49patient's journey, like when they're referred for electrophysiological
- 1:52evaluation and treatment at Community Memorial Healthcare.
- 1:55Take us through that process, the journey, if you will.
- 1:58Dr. Jonathan Dukes:
- 1:58Yeah.
- 1:58So generally, these symptoms and these conditions are discovered either by
- 2:03primary care doctors, or sometimes from emergency room doctors and hospitalists
- 2:08when you're admitted to the hospital.
- 2:10And what happens is patients come in with complaints of passing out
- 2:13or fatigue or rapid heart rates or palpitations, something feeling off.
- 2:18And often, there's an EKG that's done, either by the primary care doctor or the
- 2:23doctor you're first encountering that notices that the rhythm isn't quite right.
- 2:27Sometimes these EKGs are still normal and involves more longer testing,
- 2:31such as wearing a heart monitor for anywhere from 24 hours to a month.
- 2:36And when the abnormal rhythms are discovered in these monitors, it prompts
- 2:39a referral, either first to cardiology or directly to electrophysiology.
- 2:43More often than not, you first see a general cardiologist that then digs a
- 2:47little bit deeper into the symptoms, does a little bit more testing, such
- 2:50as those long-term monitors like I suggested, that then results in a
- 2:53referral to an electrophysiologist.
- 2:56Host: Right.
- 2:56Yeah.
- 2:57And then, from there, Dr.
- 2:58Dukes would take over, if you will.
- 3:00And one of the things you might do with some patients, Doctor,
- 3:02is pulsed field ablation.
- 3:04I like just saying that.
- 3:05It sounds cool, pulsed field ablation.
- 3:07And I've been hearing more about that.
- 3:08So, what is it, and how does it differ from traditional ablation techniques?
- 3:13Dr. Jonathan Dukes:
- 3:13So, one of the ways that we treat the heart rhythms that are too fast,
- 3:16especially the ones that are irregular, is we do something called ablation.
- 3:19Historically, for years, we were doing something called radiofrequency
- 3:23ablation or sometimes cryoablation.
- 3:25The way to think about ablation is radiofrequency ablation is hot ablation.
- 3:29It's a long catheter, usually with a small metal tip about three millimeters
- 3:33wide that's at the tip, and that tip can emit very high frequency
- 3:38radio waves that's at a high power.
- 3:40And what essentially it does is it cooks the tissue that's nearby.
- 3:43Problem is t heats up the tissue to nearly 50 degrees centigrade.
- 3:47That heat can spread out from the heart tissue into the lungs,
- 3:50nerves, and surrounding nerves and vessels and other tissues and cause
- 3:54damage to those tissues as well.
- 3:56So, we had to work really hard not to damage those other tissues.
- 3:59In the terms of cryoablation, there was a catheter or a balloon that got
- 4:03really cold full of nitroglycerin that would freeze the heart muscle.
- 4:06But again, that thermal energy, that really cold temperature of -20 degrees
- 4:11centigrade would then spread out from the tissue and damage the surrounding tissue.
- 4:16We went an entirely different direction with pulsed field ablation.
- 4:19Pulsed field ablation is a catheter that emits about 2,000 volts of energy right
- 4:24from the tip of that catheter and from its electrodes into the muscle tissue.
- 4:28That energy is non-thermal.
- 4:30And so, it's very localized.
- 4:31That 2,000 volts of energy only affects the tissue about five
- 4:35millimeters deep within the muscle.
- 4:37And beyond that, the energy is dissipated enough that the nerves surrounding the
- 4:41heart, all of the blood vessels, the lung tissue, the lining of the heart,
- 4:45the lining of the lungs, those are left entirely untouched and undamaged.
- 4:49So, you don't get collateral damage outside of that, that five-millimeter
- 4:53zone of heart muscle that you're ablating.
- 4:55And so, we're much more localized and have much less complications.
- 4:59Studies have shown that there's less damage to the phrenic nerve, so the
- 5:03nerve that goes to your diaphragm, which allows you to breathe.
- 5:06So, the chance of that getting damaged is nonexistent.
- 5:09There's less chance of causing ulcers in the esophagus that runs behind the
- 5:12heart, which was a big and very, very serious complication that we could have
- 5:16with a radiofrequency or cryoablation.
- 5:18Complications like these don't happen with this new type of ablation.
- 5:21Host: Amazing.
- 5:22Are there some patients that maybe are a better candidate
- 5:25for this type of procedure?
- 5:26Dr. Jonathan Dukes:
- 5:26Yeah.
- 5:26This type of procedure, we've been doing for about two years now.
- 5:30And it's pretty much taken over the ablation for a disease called atrial
- 5:34fibrillation, which is a disease that we ablate mostly in the left atria by
- 5:38ablating around the pulmonary veins to make them electrically silent.
- 5:42Smart French physicians in the 1990s discovered that a lot of
- 5:46atrial fibrillation starts within these veins that bring blood back
- 5:49from the lungs into the left atria.
- 5:52And there's signals of electricity sparking from these veins that
- 5:55are abnormal, that shouldn't be coming from these veins, and
- 5:58these are what's triggering and starting the atrial fibrillation.
- 6:01And if we could electrically silence the veins, we can make the AFib stop.
- 6:05Pulsed field ablation works really well for this because these veins
- 6:09are near important structures that we don't want to damage, and it
- 6:11isolates them both safely and quickly.
- 6:14By doing a pulsed field ablation, we can get the ablation done in half
- 6:18the time, usually well less than an hour, which used to take an hour and
- 6:21a half to two hours to do a procedure.
- 6:23Now, we can do it in about 45 minutes with more safety, which
- 6:27has been a very, very amazing and incredible change in our field.
- 6:31Patients that have other arrhythmias such as SVTs, supraventricular
- 6:36tachycardias, atrial flutters, those are still best served for
- 6:39the moment by standard RF ablation.
- 6:41So, we still do those ablations with our radiofrequency ablation generally.
- 6:44But the field has changed and new catheters are coming out
- 6:47and new catheter types that can better approach other arrhythmias.
- 6:50We're going to start doing ablations of a condition called ventricular
- 6:53tachycardia, which is in the lower chambers with pulsed field ablation.
- 6:56We did our first case as part of a trial last December.
- 6:59But now, the catheter just got FDA approval, so we'll start be using this
- 7:03catheter more regularly in the lab and being able to use it on these other
- 7:07more higher-risk ablations that we call ventricular tachycardia ablations.
- 7:12Host: Yeah.
- 7:12And you mentioned the trials there, and I wanted to have you sort of toot
- 7:14your own horn a little bit just to what you folks have been doing there,
- 7:17how it's benefiting patients, other medical providers, doctors and such.
- 7:22Just tell us what you guys have been up to.
- 7:23Dr. Jonathan Dukes:
- 7:23So, the EP space, the electrophysiology space is pretty amazing because the field
- 7:28is changing very quickly and very rapidly.
- 7:31The radiofrequency and cryoablation catheters we were using were relatively
- 7:34unchanged besides some changes, some basic features for really 25 years.
- 7:40And then, about two and a half years ago, we ended up starting to use
- 7:43these pulsed field ablation catheters.
- 7:45And it's caused a wealth of both new ways of using these catheters, approaching
- 7:48the diseases, but also it's required us to do testing, one, to make sure that
- 7:52they are as safe as advertised; and two, to understand how we can best use them.
- 7:57And so, this has resulted in a number of trials that are both sponsored by
- 8:00different institutions as well as by different companies to really get a handle
- 8:04on how's the best way we can use these catheters, and really, what is their true
- 8:08safety profile and how effective are they?
- 8:10Community Memorial Hospital has been very active in this space, and I've
- 8:14had the opportunity to act as the principal investigator for a number
- 8:16of different trials in the EP space that we've been participating in.
- 8:19Most recently, we just published our most recent research in the New
- 8:23England Journal of Medicine in a trial called the AVANT GUARD Trial.
- 8:26This trial was done in association with Boston Scientific, which
- 8:29is the study sponsor, and it was looking at the FARAWAVE catheter in
- 8:33its use in persistent AF patients.
- 8:36Persistent AF patients are patients that have the most severe
- 8:39form of atrial fibrillation.
- 8:40This atrial fibrillation is constant, doesn't stop, doesn't come and go.
- 8:43And this trial was looking to see if we could use pulsed field ablation
- 8:46catheters as a first-line therapy, meaning that we could go straight
- 8:50towards ablation and not have to try medicines first or other therapy options.
- 8:55And what it found is that there was a much higher rate of conversion in
- 8:58normal sinus rhythm and staying in normal sinus rhythm if you use the
- 9:02FARAWAVE catheter compared to medicines in a traditional cardioversion,
- 9:06which is a very exciting finding.
- 9:08We also found that we were able to treat these patients in well less than
- 9:11an hour with a simple procedure, and most patients went home the same day.
- 9:14The safety profile was good.
- 9:16There were some small findings of complications, but the complications
- 9:19were very rare and were about similar to what was seen with
- 9:22cardioversions and medicines.
- 9:24Host: Right.
- 9:25Yeah.
- 9:25And just trying to, you know, relate this for patients, you know, like having
- 9:29all of this tech, right, in the hands of experts right there at Community
- 9:32Memorial Hospital is so amazing.
- 9:34And maybe you can just discuss that a little bit.
- 9:36Like, how does this all translate to them?
- 9:37How does this benefit the patients?
- 9:39Dr. Jonathan Dukes:
- 9:39Well, it is really exciting, because it means that we're often the first
- 9:43hospital in the area to get some of these advanced technologies.
- 9:46So, the pulsed field ablation, we started doing the AVANT GUARD trial
- 9:50before it was FDA-approved, meaning that the only way you could get pulsed
- 9:54field ablation really in, in Southern California was only at a couple
- 9:57centers, and ours was included in that.
- 10:00Two centers were doing pulsed field ablation in Southern
- 10:02California when we started it.
- 10:04It also means that we have the most experience with pulsed field
- 10:06ablation, since we were one of the first centers to start using it.
- 10:10We also have early access to catheters from a wide variety of the companies that
- 10:14are offering pulsed field ablation at this time, as well as traditional RF ablation.
- 10:18New advances usually come first to our center because of
- 10:20the studies that we're doing.
- 10:22We're still involved in other studies with radiofrequency ablation.
- 10:24We're involved in studies looking at ablation of ventricular tachycardia.
- 10:29We're also involved in studies looking at new types of ways of managing the
- 10:32strokes in atrial fibrillation, such as the conformal trial, which is a new type
- 10:36of left atrial appendage closure device, as well as the newest form of the Watchman
- 10:39device, which is the most common device used to close the left atrial appendage.
- 10:43And these are to reduce stroke risk in atrial fibrillation.
- 10:46So to get the most advanced care, often people think they need to go down into Los
- 10:50Angeles to a large university hospital.
- 10:52This actually can be done locally here in Ventura County at Community Memorial
- 10:55Hospital, and you can get the most advanced care and the newest care using
- 11:00the newest technology right here at home.
- 11:02Host: Right.
- 11:02Just down the street.
- 11:03Talk about pulsed field ablation, and do you see it, like, really sort of
- 11:07shaping the future of electrophysiology?
- 11:09Like, is this going to be the gold standard, and it's
- 11:11just already in your hands?
- 11:13Dr. Jonathan Dukes:
- 11:13It really does seem that way.
- 11:15I mean, whenever a new technology comes out, you always have to be a little
- 11:18skeptical to make sure that there isn't untoward problems or just not going
- 11:23to work quite as well as advertised.
- 11:24In the last two years, especially in the atrial fibrillation space, it really seems
- 11:29like it's been working as advertised.
- 11:30The safety profile has been very robust, meaning that we're not seeing a lot
- 11:35of complications with this catheter, not like we saw with the old catheter.
- 11:39We can ablate without having to be scared that something bad is going
- 11:42to happen one to two weeks down the line, that there's going to be an ulcer
- 11:44that develops and suddenly there's going to be bleeding or that patient's
- 11:47going to have problems breathing because they got some nerve damage.
- 11:50We also are able to treat more patients because the cases aren't taking as long.
- 11:54The other thing to think about is that now as we're starting to move in new
- 11:57spaces such as ventricular tachycardia, more research is needed because, yes,
- 12:01we have this brand-new catheter that can treat our VT patients or ventricular
- 12:04tachycardia patients better, we think.
- 12:07We really need to prove it; hence, the reasons that we're
- 12:09still doing more studies.
- 12:11But the data profile was so positive,
- 12:15it appears to be
- 12:16Dr. Jonathan Dukes:
- 12:16so beneficial in the AFib space that we feel that it will likely
- 12:20be the same in the VT space.
- 12:22And so, we're very happy to offer these trials to our patients because our feeling
- 12:26is that based on what we saw in atrial fibrillation, it's going to be just as
- 12:30good or better in ventricular tachycardia.
- 12:33Part of the reason why I think better is because we can ablate deeper.
- 12:35The lower chamber of the heart muscle is thicker.
- 12:37So, the problem with the radiofrequency ablation is we
- 12:40couldn't get as deep as we needed.
- 12:41We were only getting about a couple millimeters.
- 12:44Here, with the newer VT-focused ablation catheters, we can get a centimeter
- 12:49deep, unheard of in the RF era.
- 12:51And so, we can really get these deep areas of disease and
- 12:54target them and get rid of them
- 12:57Host: it's amazing and it's always educational and inspiring to have you on.
- 13:00I always feel good about the future of things related to what you do, of course,
- 13:04and other things at Community Memorial.
- 13:05I'll just give you a chance here at the end, maybe if you could just pick
- 13:08one, I'm sure there are thousands, but a memorable case or story that
- 13:12really illustrates the impact of electrophysiology on a patient's life.
- 13:17Dr. Jonathan Dukes:
- 13:17I feel honored to be part of this specialty, because many parts of medicine,
- 13:20what we're doing is managing disease and we're not getting rid of disease.
- 13:24And I think the thing that's really amazing about electrophysiology and
- 13:26attracted it to me in the first place is that we have this opportunity to
- 13:29actually get rid of disease, that we can stop and cure as opposed to just manage.
- 13:35And I can think of a patient that we were dealing with back in December.
- 13:38There was an amazing patient that had come in that had had ventricular
- 13:41tachycardia, that was this lower chamber arrhythmia that was affecting their life.
- 13:46They had a defibrillator, which is a special type of pacemaker that is
- 13:49designed to bring someone to life if they were to collapse at home, and they
- 13:52were getting shocks over and over and over again from their defibrillator.
- 13:57So, we brought them in, and we were using this new PFA technology under a trial
- 14:02to be able to ablate their ventricular scar, where this VT, this ventricular
- 14:07tachycardia arrhythmia was coming from.
- 14:08And they'd been ablated other areas and the traditional
- 14:11ablation had not been successful.
- 14:13And we were able to go in and use this new type of ablation catheter, the one that
- 14:17we're going to start using commercially, which means with FDA approval and we
- 14:20were able to use it in their case.
- 14:21And we were able to find the source of the arrhythmia, which was in a very
- 14:25difficult, very deep place, and we were able to ablate it with this new catheter.
- 14:28And then, as we've watched him, as the months have been going forward, the
- 14:31ventricular tachycardia has gone away.
- 14:33We no longer see any more of these arrhythmias.
- 14:36The shocks aren't occurring.
- 14:37And we're thrilled that we were able to do this.
- 14:39We've been able to help other patients with this catheter
- 14:41as part of the trial as well.
- 14:42But this gentleman, I think of very clearly because his quality of life had
- 14:46been so affected by getting repeated shocks from his defibrillator that
- 14:50were causing significant pain and discomfort, and we were able to make them
- 14:53go all away using this new technology, PFA, when the old radiofrequency
- 14:55ablation technology had failed.
- 14:59Host: Right.
- 15:00Yeah.
- 15:00I'm sure you could go through a long list of patients that have
- 15:04benefited patients' families.
- 15:05We'll leave it at that today.
- 15:07As I said, great stuff, educational, just really inspiring.
- 15:10Thank you so much.
- 15:11Dr. Jonathan Dukes:
- 15:11No, my pleasure.
- 15:12Thanks, Scott.
- 15:12Host: And to learn more, visit mycmh.org/heart
- 15:17And if you found this podcast helpful, please share it on your social channels
- 15:20and check out the entire podcast library for additional topics of interest.
- 15:23I'm Scott Webb.
- 15:24Thanks for listening.
- 15:25This is Wise and Well, presented by Community Memorial Healthcare.